Stroke (CVA) or Transient Ischemic Attack
12
6
6
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Understanding and Enhancing Human Health and Movement
Trunk Impairment Scale - Adaptation and Validation in French
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)
Improve Medication Adherence Among Stroke Survivors in Rural Kentucky
Comparison of Eversion and Conventional Techniques in Carotid Endarterectomy
Evaluating the Effect of Nurse-Led Stroke Transitional Care in Tanzania
Predictive Value of Witness-derived Secondary Cincinnati Prehospital Stroke Scale Scores in Suspected Stroke
Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors
COAST Study - Cholesterol Optimization After Stroke
Cilostazol for Prevention of Recurrent Stroke Trial
Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes